| S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1 T Fujiwara, A Sato, M El-Farrash, S Miki, K Abe, Y Isaka, M Kodama, Y Wu, ... Antimicrobial agents and chemotherapy 42 (6), 1340-1345, 1998 | 167 | 1998 |
| Generation and Characterization of an HIV-1 mutant resistant to HIV-1 protease inhibitors KT El-Farrash MA, Kuroda MJ J.Virol 68 (1), 233 - 239, 1994 | 123* | 1994 |
| Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study M Abdel-Wahab, M Mostafa, M Sabry, M El-Farrash, T Yousef Hepatogastroenterology 55 (86-87), 1754-1759, 2008 | 46 | 2008 |
| In Vitro Infection of Immortalized Primary Hepatocytes by HCV Genotype 4a and Inhibition of Virus Replication by Cyclosporin MA El‐Farrash, HH Aly, K Watashi, M Hijikata, H Egawa, K Shimotohno Microbiology and immunology 51 (1), 127-133, 2007 | 31 | 2007 |
| 2,3 Dimercapto-1-Propanol inhibits HIV-1 Tat Activity, Viral Production and Infectivity in vitro MM Kubota S, El-Farrash MA AIDS Research and Human Retroviruses 6 (7), 919 - 925, 1990 | 25 | 1990 |
| Inhibition of HIV replication in a Human T-cell line by Antisense RNA expressed in the cell FS Gyotoku JI, El-Farrash MA Virus Genes 5 (3), 189 - 202, 1991 | 21* | 1991 |
| Impaired infectivity of HIV-1 after a single point mutation in the pol gene to escape the effect of protease inhibitors in vitro CS Kuroda MJ, El-Farrash MA Virology 210, 212- 216, 1995 | 18 | 1995 |
| Sporadic Carriers of Human T-Lymphotropic Virus Type I in Northern Egypt. HS 1- El-Farrash MA, Badr MF Microbiology and Immunology 32 (9), 981 - 984, 1988 | 17 | 1988 |
| Retention of HIV-1 inside infected MOLT-4 cells in association with adhesion-induced cytoskeleton reorganization S Choudhury, MA El-Farrash, MJ Kuroda, S Harada AIDS 10 (4), 363-368, 1996 | 13 | 1996 |
| Allopurinol as a potential therapeutic agent for recurrent herpes labialis YJMEMSE El-Farrash MA J Med Dent Sci 50, 147 - 154, 2003 | 8 | 2003 |
| The Mycoplasma-related inhibitor of HIV-1 Reverse Transcriptase has a DNase activity and is present in the Particle-free supernatant of contaminated cultures KMJ El-Farrash MA, Kannagi M J. Virological Methods 47, 73- 82, 1994 | 8 | 1994 |
| Isolation of human T-cell leukemia virus type I from a transformed T-cell line derived spontaneously from lymphocytes of a seronegative Egyptian patient with mycosis fungoides MA El-Farrash, HA Salem, MJ Kuroda, K Morizono, M Kannagi, S Harada | 7 | 1995 |
| Serum Aflatoxin level as a predictor of Hepatocarcinogenesis in HCV-infected Egyptians AWMRMS El-Farrash MA Egypt J Med Mirobiol 17 (1), 83 - 90, 2008 | 4 | 2008 |
| HEV epidemiology in Northern Egypt is modified by the predominant HCV infection TSAEMA El-Farrash MA Egypt J Med Mirobiol 14 (1), 101 - 109, 2005 | 3* | 2005 |
| Synergistic Infectivity of Highly and Minimally Infectious clones of HIV in vitro. MTHS El-Farrash MA J. Infectious diseases 161, 1010 - 113, 1990 | 3 | 1990 |
| Syncytium-inducing Capacity of Human Immunodeficiency Virus (HIV): Analysis by the use of cloned viruses. EFMA Harada S Microbiology and immunology 33 (7), 549 - 559, 1989 | 3 | 1989 |
| HCV core protein stimulates Telomerase activity and Nuclear factor Kappa B in activated hepatocytes or cells lacking p53: A model for HCV oncogenesis in hepatocellular carcinoma EFMA Nakamura M. Egypt J Med Mirobiol 13 (4), 831 - 838, 2004 | 2* | 2004 |
| A novel approach to develop disinfecting dental cement GMHEFMA Abdel-Aziz KM Egypt Dental J 48, 1267 - 1272, 2002 | 2 | 2002 |
| Epidemiology of hepatitis C virus in an Egyptian village MS Rizk, MA El-Farrash, W Zaghloul, A Omar, S Hawas, A E-Gilany, ... Journal of environmental sciences 22, 103-24, 2001 | 2 | 2001 |
| HTLV-1 associated myelopathy/tropical spastic paraparesis in Egypt A Hassan, A Hassan, A El-Gohary, M El-Farrash, F Kawano Journal of Neurovirology 2 (5), 356-356, 1996 | 2 | 1996 |
